Executive brings more than 25 years of experience in life sciences SAN JOSE, Calif. – Molecular Devices, LLC., a leading high-performance life science solutions provider and an operating company in the life sciences segment of Danaher Corporation (NYSE:DHR), today announced Mary Duseau’s appointment as its new president, succeeding interim president, Greg Milosevich. “Mary brings more than 25 […]
Proceeds to launch new RNA sequencing products, expand production capacity, develop new technologies and open US subsidiary. LAUSANNE, Switzerland — Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced today the closing of a CHF 2.8 million ($3.2 million) extension to its seed financing. The round was led by the Novalis […]
Key appointment to lead global commercial launch of eProtein Discovery platform Cambridge, UK: Nuclera, the biotechnology company enabling rapid protein expression and purification screening through its benchtop protein platform, today announced the appointment of Joseph Bertelsen as Chief Commercial Officer (CCO). With over 20 years’ commercial leadership experience in the life science tools and drug development […]
Following discussions with the board, the company’s founders Erik Gatenholm and Hector Martinez are leaving BICO after eight years. “I want to thank Erik and Hector for their efforts. Without them, the company would not have existed, let alone contributed to the change in the industry,” says Rolf Classon, Chairman of the Board. “I wish […]
New ResolveDNA® and ResolveOME™ single-cell kits generate sequencing-ready libraries in under eight hours DURHAM, N.C. – BioSkryb Genomics, a company ushering in the next generation of single-cell technology, today announced the commercial launch of its new ResolveDNA Whole Genome and ResolveOME Whole Genome and Transcriptome Single-Cell Core Kits, which are now available to U.S. and international […]
CAMBRIDGE, Mass. – Vizgen, Inc., the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, is very pleased to announce that, on March 7, 2024, the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) denied 10x Genomics Inc.’s petition to institute an Inter Partes Review […]
The next generation of the company’s leading single cell technology architecture, GEM-X, enables higher performance at larger scale and lower cost PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that it has started shipping the first two products powered by the GEM-X technology architecture, Chromium Single Cell Gene […]
OAKLAND, Calif. and SALT LAKE CITY, UT – Fabric Genomics, the leader in artificial intelligence (AI)-powered next generation sequencing interpretation, is announcing a new partnership with Intermountain Children’s Health to analyze the whole genomes of children sequenced by the Broad Clinical Labs to help speed diagnosis of kids who may have genetic diseases. This collaboration is a milestone in helping […]
The Cultivated B (TCB) today announced the name change of its Canadian subsidiary, now embracing a broader mission. Formerly called The Cultivated B Canada and located in Burlington, Ontario, n!Biomachines (pronounced “n factorial biomachines”) is dedicated to fulfilling the commercial scalability and viability potential of industrial cellular agriculture technologies across a number of product categories. […]
SAN DIEGO — Armonica Technologies, Inc., a pioneer in sample-prep free direct optical DNA sequencing, today announced the appointment of life science leader Todd Dickinson to the Board of Directors. Armonica Technologies is a MedTech company focused on developing its advanced long-read sequencing platform for precision medicine applications. The company utilizes nanochannels to transport individual nucleic acid molecules through […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
